Skip to main content
ANNX
NASDAQ Life Sciences

Annexon Posts $51.2M Q3 Loss, Adds $200M Oxford Credit Facility Ahead of Q4 BLA Filing

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.23
Mkt Cap
$801.92M
52W Low
$2.54
52W High
$7.18
52W Position info
67% above low
Off High info
41% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ANNX sits 67% above its 52-week low of $2.54.

Summary

Annexon closed Q3 with a $51.2 million net loss, or $0.25 per share, narrower than the $54.9 million loss a year earlier, and $213.4 million in cash and short-term investments that management says funds operations into 2028. R&D fell to $41.4 million from $49.7 million as contract manufacturing for the tanruprubart filings wound down, while G&A rose to $10.9 million from $7.3 million. The bigger news is financing: a strategic credit facility of up to $200 million with Oxford Finance, with $50 million drawn at closing and another $100 million available on vonaprument and tanruprubart milestones. Two binary readouts sit in the next two quarters — the tanruprubart BLA submission is expected in Q4 2026, and the ARCHER II Phase 3 Month 15 primary endpoint assessment is also expected in Q4 2026, with sub-study results in Q1 2027 if the DMC recommends the endpoint was met. The cash position plus the new facility removes near-term financing risk, but the stock still hinges on those two events.

At the time of this announcement, ANNX was trading at $4.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $801.9M. The 52-week trading range was $2.54 to $7.18. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ANNX - Latest Insights

ANNX
Nov 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.23
Real-time Price: $4.22 info
Change: -$0.010 (-0.24%) info
Market Cap: $794.337M info
ANNX
Aug 12, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $4.22 info
Change: -$1.13 (-21%) info
Market Cap: $794.337M info
ANNX
Aug 12, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.01
Real-time Price: $4.22 info
Change: -$0.7865 (-16%) info
Market Cap: $794.337M info
ANNX
Aug 12, 2026, 6:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.46
Real-time Price: $4.22 info
Change: -$1.24 (-23%) info
Market Cap: $794.337M info
ANNX
Aug 12, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.21
Real-time Price: $4.22 info
Change: -$0.990 (-19%) info
Market Cap: $794.337M info